Global Neurosurgery Devices Industry to 2026

0

DUBLIN, September 1, 2021 / PRNewswire / – The “Neurosurgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2021-2026” report has been added to ResearchAndMarkets.com offer.

Research and Markets logo

The global neurosurgery devices market has shown moderate growth during the period 2015-2020. Neurosurgery devices refer to various tools and instruments used to perform surgeries and treat various pathologies of the central and peripheral nervous systems. They are primarily used to diagnose, prevent, and treat conditions such as Parkinson’s disease, Alzheimer’s disease, depression, epilepsy, and head and spinal cord injuries. Some of the commonly used devices include neurostimulation devices, neurosurgical navigation devices, and cerebrospinal fluid (CSF) management devices, such as curettes, dissectors, elevators, and rodents. These tools help to perform microsurgery, discectomies, elevate the periosteum below the temporalis muscle, and adjust the skull bone during surgeries.

One of the key factors driving the growth of the market is the increasing prevalence of various neurological disorders across the world. In addition, the increase in the geriatric population, which is more susceptible to neurological conditions and other medical conditions, is also driving the growth of the market. The masses are also increasingly aware of the health and the availability of effective therapeutic alternatives for neurological disorders, which is helping in the growth of the market. Therefore, there is a growing preference for neuroendoscopic surgeries over traditional brain surgeries. For example, various neurostimulation devices are used to send electrical impulses to targeted sacral nerves and perform deep brain stimulation.

In addition, various technological advancements, including the development of innovative minimally invasive (MI) equipment, such as flow bypass, liquid embolism and clot recovery devices, neuroendovascular stents and balloon catheters, act as another growth factor. Other factors, including improved healthcare infrastructure, as well as deeper research and development (R&D) activities, are expected to drive the market. Looking ahead, the publisher expects the global neurosurgery devices market to grow at a CAGR of approximately 8% during 2021-2026.

Competitive landscape:

The report also analyzed the competitive landscape of the market with some of the major players being Abbott Laboratories, Ackermann Instrumente GmbH, Adeor Medical AG, B. Braun Melsungen, Biotronik, Boston Scientific Corporation, DePuy Synthes Inc., Integra Lifesciences, Johnson & Johnson Services Inc., Medtronic Inc., Nevro Corporation, Nihon Kohden Corporation, Penumbra Inc., Stryker Corporation, etc.

Key questions addressed in this report:

  • How has the global neurosurgery devices market performed so far and how will it perform in the years to come?

  • What are the main regional markets?

  • What has been the impact of COVID 19 on the global neurosurgery devices market?

  • What is the distribution of the market according to the type of product?

  • What is the market split depending on the application?

  • What is the distribution of the market according to the end user?

  • What are the different stages of the industry value chain?

  • What are the main factors and challenges for the industry?

  • What is the structure of the global neurosurgery market and who are the major players?

  • How competitive is the industry?

Main topics covered:

1 Preface

2 Scope and methodology

3 Executive summary

4 Presentation
4.1 Overview
4.2 Key Industry Trends

5 Global Neurosurgery Devices Market
5.1 Market overview
5.2 Market performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market breakdown by product type
6.1 Neurostimulation devices
6.1.1 Market trends
6.1.2 Market Forecast
6.2 Neurointerventional devices
6.2.1 Market trends
6.2.2 Market Forecast
6.3 Neurosurgical navigation systems
6.3.1 Market trends
6.3.2 Market Forecast
6.4 Cerebrospinal fluid (CSF) management devices
6.4.1 Market trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market trends
6.5.2 Market Forecast

7 Market split by application
7.1 Spinal cord stimulation
7.1.1 Market trends
7.1.2 Main types
7.1.2.1 Chronic pain
7.1.2.2 Back surgery failure syndrome
7.1.2.3 Ischemia
7.1.3 Market Forecast
7.2 Deep brain stimulation
7.2.1 Market trends
7.2.2 Main types
7.2.2.1 Parkinson’s disease
7.2.2.2 Tremor
7.2.2.3 Depression
7.2.2.4 Others
7.2.3 Market Forecast
7.3 Neuroendoscopy
7.3.1 Market trends
7.3.2 Main types
7.3.2.1 Transnasal neuroendoscopy
7.3.2.2 Intraventricular neuroendoscopy
7.3.2.3 Transcranial neuroendoscopy
7.3.3 Market Forecast

8 Market breakdown by end user
8.1 Hospitals
8.1.1 Market trends
8.1.2 Market Forecast
8.2 Outpatient surgical centers
8.2.1 Market trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market trends
8.3.2 Market Forecast

9 Market breakdown by region

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value chain analysis

Analysis of the five forces of 12 carriers
12.1 Overview
12.2 Bargaining power of buyers
12.3 Bargaining power of suppliers
12.4 Degree of competition
12.5 Threat of new entrants
12.6 Threat of substitutes

13 Price indicators

14 Competitive landscape
14.1 Market structure
14.2 Key players
14.3 Profiles of key players
14.3.1 Abbott Laboratories
14.3.1.1 Company presentation
14.3.1.2 Product portfolio
14.3.1.3 Finances
14.3.1.4 SWOT Analysis
14.3.2 Ackermann Instrumente GmbH
14.3.2.1 Company overview
14.3.2.2 Product portfolio
14.3.3 Adeor Medical AG
14.3.3.1 Company overview
14.3.3.2 Product portfolio
14.3.3.3 Finances
14.3.4 B. Braun Melsungen
14.3.4.1 Company overview
14.3.4.2 Product portfolio
14.3.4.3 Finances
14.3.4.4 SWOT Analysis
14.3.5 Biotronik
14.3.5.1 Company overview
14.3.5.2 Product portfolio
14.3.5.3 Finances
14.3.5.4 SWOT Analysis
14.3.6 Boston Scientific Society
14.3.6.1 Company overview
14.3.6.2 Product portfolio
14.3.6.3 Finances
14.3.6.4 SWOT Analysis
14.3.7 DePuy Synthes Inc.
14.3.7.1 Company overview
14.3.7.2 Product portfolio
14.3.8 Integra Life Sciences
14.3.8.1 Company overview
14.3.8.2 Product portfolio
14.3.9 Johnson & Johnson Services Inc.
14.3.9.1 Company overview
14.3.9.2 Product portfolio
14.3.10 Medtronic inc.
14.3.10.1 Company overview
14.3.10.2 Product portfolio
14.3.11 Nevro Company
14.3.11.1 Company presentation
14.3.11.2 Product portfolio
14.3.11.3 Finances
14.3.12 Nihon Kohden Corporation
14.3.12.1 Company presentation
14.3.12.2 Product portfolio
14.3.12.3 Finances
14.3.12.4 SWOT Analysis
14.3.13 Penumbra inc.
14.3.13.1 Company presentation
14.3.13.2 Product portfolio
14.3.13.3 Finances
14.3.14 Stryker Company
14.3.14.1 Company presentation
14.3.14.2 Product portfolio
14.3.14.3 Finances
14.3.14.4 SWOT Analysis

For more information on this report, visit https://www.researchandmarkets.com/r/l71uey

Media contact:

Research and markets
Laura Wood, senior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1904
Fax (outside the United States): + 353-1-481-1716

Cision

Cision

View original content: https://www.prnewswire.com/news-releases/worldwide-neurosurgery-devices-industry-to-2026—featuring-abbott-laboratories-ackermann-instrumente-and-adeor-medical-among – others-301367463.html

SOURCE Research and Markets


Source link

Leave A Reply

Your email address will not be published.